Addressing Barriers in Vaccination Uptake and Integration

Merck Grant Funded Program

The overall goal of this program is to address the barriers in vaccination uptake and integration. 

Credits: 1.0 contact hours; 1.0 are Pharmacology

Expiration Date: December 31st, 2025

$10.00

LEARNING OBJECTIVES

Following this targeted and comprehensive educational program, participants will report:

1. Effectively integrate vaccine education, information and
implementation into clinical practice
2. Confidently administer vaccines in adherence to the recommended guidelines and intervals to advance disease prevention and vaccine uptake
3. Navigate, initiate and foster patient and caregiver support, informed decision-making, and education
4. Advance disease prevention opportunities by identifying and addressing factors related to vaccine hesitancy

Expected Outcomes: 

At the conclusion of this program, expected outcomes of participants should include the ability to self-report:
(a) Advancement in their primary care knowledge and skills for administering vaccines across patient cohorts;
(b) A change in their clinical practice performance based on the latest guidelines, recommendations and skills learned;
(c) An increase in vaccine uptake and disease prevention opportunities; and,
(d) Utilization of evidence-based strategies to eliminate vaccine barriers.

CE INFORMATION

Obtain Your Credits

To earn credits for this activity, navigate to the Content(s) tab and complete all course components in the following order: 1) watch the course presentation video; 2) complete the course evaluation; 3) pass the post-test with a score of 2/3 (66.7%) or higher. You may retake the post-test until a passing score is achieved, at which point you will be able to view/print a copy of your certificate of completion. This online certificate will also be saved within your profile 'My Dashboard' -> 'Transcript/Certificates Earned'  for future access.

Designation Statement

NPACE designates this educational activity for a maximum of 1.00 contact hours, of which 1.0 is pharmacology credit. Participants should claim only credit commensurate with the extent of their participation in the activity.

Accreditation Statement

Nurse Practitioner Associates for Continuing Education (NPACE) is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation (ANCC).

In addition to ANCC, NPACE is approved as a provider of continuing education in nursing by: the California Board of Registered Nursing, Provider Number CEP8720 and Florida CE Broker #50-1476.

DISCLOSURES

Faculty

Contributing faculty, Wendy Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP has disclosed:

Merck, Sanofi, Pfizer, Moderna, Seqirus Speaker bureau and consultant Vaccines All vaccine

AbbVie and Biohaven Speaker bureau Migraines Nurtec, Ubrelvy, and Qullipt

Idorsia Speaker bureau and consultant Insomnia Quvivq

Shield, Glaxo, Bayer Consultant IDA, Pain/OA, CKD Accrufer, Voltaren Gel, Kerendi

Planners

All planners and contributors involved in this educational activity have disclosed no relevant financial relationships. 

Disclaimer

The material presented in this continuing education program is being made available for educational purposes only and is not intended to represent the best or only methods, medications and/or guidelines appropriate for the medical situation discussed. Rather the material is intended to present an approach, view, statement, or opinion of the presenter(s), which may be helpful, or of interest to other practitioners and should not be used by clinicians without the evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. NPACE disclaims any liability, loss, injury, or damage incurred as a consequence, directly or indirectly, of the use and application of any information given in a presentation.

Disclosure of Unlabeled Use

This educational activity may mention the uses of products that are not approved by the FDA for the indication(s) being discussed. The presenter(s) are instructed to notify participants when they are discussing unapproved uses or investigational agents. The opinions related to unapproved uses of products are solely those of the presenter(s) and are not endorsed or recommended by NPACE. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Commercial Support

There is no commercial support for this activity.